Drug screening using reprogramming resistance to overcome resistance to ALK-targeted therapy

被引：0
|
作者：
Utsumi, Takahiro [1 ]
Uchibori, Ken [2 ]
Nishio, Makoto [2 ]
Yamada, Yasuhiro [3 ]
Okamoto, Isamu [4 ]
Katayama, Ryohei [1 ]
机构：
[1] JFCR, Canc Chemother Ctr, Div Exp Chemother, Tokyo, Japan
[2] JFCR, Canc Inst Hosp, Dept Thorac Med Oncol, Tokyo, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Resp Med, Fukuoka, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-1010
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [41] The role of RICTOR amplification in targeted therapy and drug resistance
    Deze Zhao
    Man Jiang
    Xiaochun Zhang
    Helei Hou
    Molecular Medicine, 2020, 26
  • [42] Overcoming multiple drug resistance in lung cancer using siRNA targeted therapy
    Naghizadeh, Sanaz
    Mohammadi, Ali
    Baradaran, Behzad
    Mansoori, Behzad
    GENE, 2019, 714
  • [43] OVERCOME RESISTANCE TO CHEMOTHERAPY BY USING DRUG SENSITIVITY AND RESISTANCE PROFILING IN T-ALL
    Cambo, B.
    La Starza, R.
    Patrizi, L.
    Rastelli, G.
    Baglione, M.
    Follini, E.
    Bertaggia, I.
    Sammarelli, G.
    Bonomini, S.
    Pierini, T.
    Bornhauser, B.
    Bourquin, J. P.
    Mecucci, C.
    Aversa, F.
    Roti, G.
    HAEMATOLOGICA, 2018, 103 : S73 - S74
  • [44] Deciphering Evolution of Targeted Therapy Resistance in EML4-ALK NSCLC
    Marusyk, A.
    Vander Velde, R.
    Marusyk, V.
    Peacock, J.
    Kenian, L.
    Haura, E.
    Scott, J.
    Marusyk, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (08) : S1547 - S1547
  • [45] HOW TO OVERCOME RESISTANCE IN MUTATION DRIVEN THERAPIES COMBINATION TARGETED THERAPY REGIMENS
    Flaherty, K. T.
    ANNALS OF ONCOLOGY, 2012, 23 : 46 - 46
  • [46] Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma
    Yeon, Minjeong
    Kim, Youngmi
    Jung, Hyun Suk
    Jeoung, Dooil
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [47] Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy
    Bobin, Charles
    Iddir, Yasmine
    Butterworth, Charlotte
    Masliah-Planchon, Julien
    Saint-Charles, Alexandra
    Bellini, Angela
    Bhalshankar, Jaydutt
    Pierron, Gaelle
    Combaret, Valerie
    Attignon, Valery
    Andre, Nicolas
    Corradini, Nadege
    Dumont, Benoit
    Mansuy, Ludovic
    Khanfar, Camille
    Klein, Sebastien
    Briandet, Claire
    Plantaz, Dominique
    Millot, Frederic
    Thouvenin, Sandrine
    Aerts, Isabelle
    Ndounga-Diakou, Lee Aymar
    Laghouati, Salim
    Abbou, Samuel
    Jehanno, Nina
    Tissot, Hubert
    Renault, Shufang
    Baulande, Sylvain
    Raynal, Virginie
    Bozec, Laurence
    Bieche, Ivan
    Delattre, Olivier
    Berlanga, Pablo
    Schleiermacher, Gudrun
    CLINICAL CANCER RESEARCH, 2024, 30 (15) : 3316 - 3328
  • [48] Deep and durable responses to ALK-targeted therapy require CD8+T cells
    Reis, Greg
    Phelabaum, Stevie
    Navarro, Andre
    Kleczko, Emily
    Heasley, Lynn
    Nemenoff, Raphael
    Schenk, Erin L.
    CANCER RESEARCH, 2024, 84 (06)
  • [49] Overcome Cancer Cell Drug Resistance Using Natural Products
    Wang, Pu
    Yang, Hua Li
    Yang, Ying Juan
    Wang, Lan
    Lee, Shao Chin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [50] Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
    Wang, Zhiwei
    Li, Yiwei
    Ahmad, Aamir
    Azmi, Asfar S.
    Banerjee, Sanjeev
    Kong, Dejuan
    Sarkar, Fazlul H.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2010, 1806 (02): : 258 - 267
12345